Although the results of coagulation testing, PAI-2 assay and increased ECLT suggest a high risk of thromboembolic complications in SCA associated with pregnancy, in our patients this did not translate into significantly higher frequency of feto-maternal complications or any evidence of placental insufficiency. Here, SERPINB2 is linked to placental insufficiency.